» Articles » PMID: 31659121

Characterization of NCS1-InsP3R1 Interaction and Its Functional Significance

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2019 Oct 30
PMID 31659121
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Inositol 1,4,5-trisphosphate receptors (InsP3Rs) are endoplasmic reticulum-localized channels that mediate Ca release from the endoplasmic reticulum into the cytoplasm. We previously reported that an EF-hand Ca-binding protein, neuronal calcium sensor 1 (NCS1), binds to the InsP3R and thereby increases channel open probability, an event associated with chemotherapy-induced peripheral neuropathy. However, the exact NCS1-binding site on InsP3R remains unknown. Using protein docking, co-immunoprecipitation, and blocking peptides, we mapped the NCS1-binding site to residues 66-110 on the suppressor domain of InsP3R type 1 (InsP3R1). We also identified Leu-89, a residue in the hydrophobic pocket of NCS1, as being critical for facilitating the NCS1-InsP3R1 interaction. Overexpression of WT NCS1 in MDA-MB231 breast cancer cells increased Ca signaling and survival, whereas overexpression of Leu-89 NCS1 variants decreased Ca signaling and survival, further suggesting the importance of this residue in the NCS1-InsP3R1 interaction. In conclusion, we show that NCS1-InsP3R1 interaction enhances intracellular Ca signaling in cells and can be modulated by altering or occluding the hydrophobic pocket of NCS1. This improved understanding of the NCS1-InsP3R1 interaction may facilitate the development of management strategies for diseases resulting from aberrant NCS1 expression.

Citing Articles

10th European Calcium Society symposium: The Ca2+-signaling toolkit in cell function, health and disease.

Speelman-Rooms F, Vanmunster M, Coughlan A, Hinrichs M, Pontisso I, Barbeau S Biol Open. 2024; 13(4).

PMID: 38661208 PMC: 11070784. DOI: 10.1242/bio.060357.


Calcium-Associated Proteins in Neuroregeneration.

Lisek M, Tomczak J, Boczek T, Zylinska L Biomolecules. 2024; 14(2).

PMID: 38397420 PMC: 10887043. DOI: 10.3390/biom14020183.


Loss of INPP5K attenuates IP-induced Ca responses in the glioblastoma cell line U-251 MG cells.

Loncke J, Luyten T, Ramos A, Erneux C, Bultynck G BBA Adv. 2023; 4:100105.

PMID: 37842182 PMC: 10568277. DOI: 10.1016/j.bbadva.2023.100105.


A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.

Ibrahim E, Munshani S, Domenicano I, Rodwin R, Nowak R, Pusztai L PLoS One. 2022; 17(10):e0275648.

PMID: 36206298 PMC: 9543876. DOI: 10.1371/journal.pone.0275648.


Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer.

Eustace A, Lee M, Colley G, Roban J, Downing T, Buchanan P Cancer Drug Resist. 2022; 5(3):560-576.

PMID: 36176752 PMC: 9511797. DOI: 10.20517/cdr.2022.41.


References
1.
Apasu J, Schuette D, LaRanger R, Steinle J, Nguyen L, Grosshans H . Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo. FASEB J. 2018; 33(4):4802-4813. PMC: 6436647. DOI: 10.1096/fj.201802004R. View

2.
Boehmerle W, Zhang K, Sivula M, Heidrich F, Lee Y, Jordt S . Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation. Proc Natl Acad Sci U S A. 2007; 104(26):11103-8. PMC: 1904151. DOI: 10.1073/pnas.0701546104. View

3.
Burgoyne R . Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007; 8(3):182-93. PMC: 1887812. DOI: 10.1038/nrn2093. View

4.
Iketani M, Imaizumi C, Nakamura F, Jeromin A, Mikoshiba K, Goshima Y . Regulation of neurite outgrowth mediated by neuronal calcium sensor-1 and inositol 1,4,5-trisphosphate receptor in nerve growth cones. Neuroscience. 2009; 161(3):743-52. DOI: 10.1016/j.neuroscience.2009.04.019. View

5.
Moore L, England A, Ehrlich B, Rimm D . Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival. Mol Cancer Res. 2017; 15(7):942-952. PMC: 5500411. DOI: 10.1158/1541-7786.MCR-16-0408. View